TNFSF13B and chronic inflammatory demyelinating polyradiculoneuropathy: In fact, it was recently confirmed by two studies that IVIG treatment resulted in a significant decrease of BAFF serum level in newly diagnosed patients affected by CIDP, which all had elevated BAFF level before treatment (52, 53).